• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts.

作者信息

Mangaonkar Abhishek A, Lasho Terra L, Finke Christy M, Gangat Naseema, Al-Kali Aref, Elliott Michelle A, Begna Kebede H, Alkhateeb Hassan, Wolanskyj-Spinner Alexandra P, Hanson Curtis A, Ketterling Rhett P, Hogan William J, Pardanani Animesh, Litzow Mark R, Tefferi Ayalew, Patnaik Mrinal M

机构信息

Department of Hematology, Mayo Clinic, Rochester, USA.

Department of Pathology, Mayo Clinic, Rochester, USA.

出版信息

Blood Cancer J. 2018 Feb 12;8(2):18. doi: 10.1038/s41408-018-0051-1.

DOI:10.1038/s41408-018-0051-1
PMID:29434284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5809387/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ef/5809387/9561bd797110/41408_2018_51_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ef/5809387/9561bd797110/41408_2018_51_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ef/5809387/9561bd797110/41408_2018_51_Fig1_HTML.jpg

相似文献

1
Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts.伴有环形铁粒幼细胞的骨髓增生异常综合征中骨髓形态学与SF3B1及ASXL1突变之间的预后相互作用
Blood Cancer J. 2018 Feb 12;8(2):18. doi: 10.1038/s41408-018-0051-1.
2
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.环形铁幼粒细胞难治性贫血伴血小板增多症（RARS-T）的生存预测因素及二代测序的作用。
Am J Hematol. 2016 May;91(5):492-8. doi: 10.1002/ajh.24332. Epub 2016 Apr 4.
3
SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.伴有环形铁粒幼细胞的SF3B1突变型骨髓增生异常综合征存在更严重的铁过载及相应的红细胞生成过多。
Leuk Res. 2016 May;44:8-16. doi: 10.1016/j.leukres.2016.02.011. Epub 2016 Feb 27.
4
Prognostic impact of mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.伴有环形铁粒幼细胞的骨髓增生异常综合征中突变和多系发育异常的预后影响：梅奥诊所对170例有效病例的研究
Haematologica. 2024 Aug 1;109(8):2525-2532. doi: 10.3324/haematol.2023.284719.
5
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.SF3B1突变可识别出伴有环形铁粒幼细胞的骨髓增生异常综合征的一个独特亚组。
Blood. 2015 Jul 9;126(2):233-41. doi: 10.1182/blood-2015-03-633537. Epub 2015 May 8.
6
SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value.SF3B1 突变在环形铁幼粒细胞性难治性贫血伴原始细胞增多性骨髓增生异常综合征中较为常见，但不具有独立的预后价值。
Blood. 2012 Jan 12;119(2):569-72. doi: 10.1182/blood-2011-09-377994. Epub 2011 Nov 17.
7
Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts.伴有环形铁粒幼细胞的骨髓增生异常综合征认识的最新进展
Br J Haematol. 2016 Sep;174(6):847-58. doi: 10.1111/bjh.14215. Epub 2016 Jul 8.
8
SF3B1 Mutation but Not Ring Sideroblasts Identifies a Specific Group of Myelodysplastic Syndrome-Refractory Cytopenia With Multilineage Dysplasia.SF3B1 突变而非环形铁幼粒细胞可鉴定出一组特定的难治性血细胞减少伴多系发育异常的骨髓增生异常综合征。
Clin Lymphoma Myeloma Leuk. 2020 May;20(5):329-339.e3. doi: 10.1016/j.clml.2020.01.005. Epub 2020 Jan 16.
9
Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis with Cooccurrent SF3B1 and MPL Gene Mutations: A Case Report and Brief Review of the Literature.伴有环形铁粒幼细胞和血小板增多症的骨髓增生异常综合征/骨髓增殖性肿瘤合并SF3B1和MPL基因突变：一例报告并文献简要回顾
Lab Med. 2020 May 6;51(3):315-319. doi: 10.1093/labmed/lmz076.
10
Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts.造血特异性Sf3b1-K700E基因敲入小鼠表现出人类骨髓增生异常综合征（MDS）中所见的剪接缺陷，但会发展为无环形铁粒幼细胞的贫血。
Leukemia. 2017 Mar;31(3):720-727. doi: 10.1038/leu.2016.251. Epub 2016 Sep 8.

引用本文的文献

1
Significance of Mutation Spots and Concurrent Gene Mutations on Prognosis and Clinical Outcomes in Myelodysplastic Syndromes With SF3B1 Mutation.SF3B1 突变的骨髓增生异常综合征中突变位点及并发基因突变对预后和临床结局的意义
Cancer Med. 2025 May;14(9):e70930. doi: 10.1002/cam4.70930.
2
Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome.DTA 突变与骨髓增生异常综合征患者共存突变的预后影响。
Mol Biol Rep. 2024 Sep 15;51(1):985. doi: 10.1007/s11033-024-09922-7.
3
Biological relevance of alternative splicing in hematologic malignancies.

本文引用的文献

1
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.骨髓增生异常综合征的靶向下一代测序与突变和 IPSS-R 之间的预后交互作用。
Am J Hematol. 2017 Dec;92(12):1311-1317. doi: 10.1002/ajh.24901. Epub 2017 Oct 20.
2
Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.伴有环状铁粒幼细胞的难治性贫血（RARS）及伴有血小板增多的RARS（RARS-T）：2017年诊断、风险分层及管理的最新进展
Am J Hematol. 2017 Mar;92(3):297-310. doi: 10.1002/ajh.24637.
3
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
剪接变异在血液系统恶性肿瘤中的生物学相关性。
Mol Med. 2024 May 17;30(1):62. doi: 10.1186/s10020-024-00839-2.
4
Prognostic impact of mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.伴有环形铁粒幼细胞的骨髓增生异常综合征中突变和多系发育异常的预后影响：梅奥诊所对170例有效病例的研究
Haematologica. 2024 Aug 1;109(8):2525-2532. doi: 10.3324/haematol.2023.284719.
5
Usefulness of New Neutrophil-Related Hematologic Parameters in Patients with Myelodysplastic Syndrome.新的中性粒细胞相关血液学参数在骨髓增生异常综合征患者中的应用价值
Cancers (Basel). 2023 Apr 26;15(9):2488. doi: 10.3390/cancers15092488.
6
Co-mutation of and Predicts Poorer Overall Survival Than Isolated or Mutations.和 共突变比单独 或 突变预测更差的总生存期。
In Vivo. 2023 May-Jun;37(3):985-993. doi: 10.21873/invivo.13172.
7
SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process.骨髓增生异常综合征中的SF3B1突变：调控整个疾病进程的潜在治疗靶点。
Front Oncol. 2023 Mar 17;13:1116438. doi: 10.3389/fonc.2023.1116438. eCollection 2023.
8
Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series.接受聚（ADP - 核糖）聚合酶（PARP）抑制剂治疗的癌症患者中的髓系恶性肿瘤：病例系列
Blood Cancer J. 2022 Jan 25;12(1):11. doi: 10.1038/s41408-022-00607-7.
9
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes.新诊断的低危骨髓增生异常综合征患者中环形铁幼粒细胞和 SF3B1 突变评估的真实世界诊断检测模式。
Int J Lab Hematol. 2021 Jun;43(3):426-432. doi: 10.1111/ijlh.13400. Epub 2020 Nov 21.
10
[Features and clinical significance of gene mutations in patients with myelodysplastic syndromes with ring sideroblasts].[伴有环形铁粒幼细胞的骨髓增生异常综合征患者基因突变的特征及临床意义]
Zhonghua Xue Ye Xue Za Zhi. 2020 May 14;41(5):379-386. doi: 10.3760/cma.j.issn.0253-2727.2020.05.004.
2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
4
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia.慢性粒单核细胞白血病中ASXL1与TET2突变之间的预后相互作用
Blood Cancer J. 2016 Jan 15;6(1):e385. doi: 10.1038/bcj.2015.113.
5
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.SF3B1突变可识别出伴有环形铁粒幼细胞的骨髓增生异常综合征的一个独特亚组。
Blood. 2015 Jul 9;126(2):233-41. doi: 10.1182/blood-2015-03-633537. Epub 2015 May 8.
6
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.验证低危骨髓增生异常综合征患者的预后模型和突变的影响。
J Clin Oncol. 2012 Sep 20;30(27):3376-82. doi: 10.1200/JCO.2011.40.7379. Epub 2012 Aug 6.
7
Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts.在世界卫生组织定义的无过多原始细胞的骨髓增生异常综合征中，环形铁幼粒细胞百分比的预后无关性。
Blood. 2012 Jun 14;119(24):5674-7. doi: 10.1182/blood-2012-03-415356. Epub 2012 Apr 26.
8
SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value.SF3B1 突变在环形铁幼粒细胞性难治性贫血伴原始细胞增多性骨髓增生异常综合征中较为常见，但不具有独立的预后价值。
Blood. 2012 Jan 12;119(2):569-72. doi: 10.1182/blood-2011-09-377994. Epub 2011 Nov 17.
9
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.环形铁幼粒细胞性难治性贫血伴多系发育异常中的体细胞 SF3B1 突变。
N Engl J Med. 2011 Oct 13;365(15):1384-95. doi: 10.1056/NEJMoa1103283. Epub 2011 Sep 26.
10
Clinical effect of point mutations in myelodysplastic syndromes.骨髓增生异常综合征点突变的临床疗效。
N Engl J Med. 2011 Jun 30;364(26):2496-506. doi: 10.1056/NEJMoa1013343.